Health Policy

Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis

On 6 Nov, 2021 By admin 0 Comments

November, 2021

Abstract

The role of inhaled corticosteroids for outpatient COVID-19 is evolving. We meta-analyzed reported clinical trials and estimated probability of any effect and number needed to treat of 50 or 20 for symptom resolution by day 14 [100%, 99.8%, 93.1%] and hospitalization [88.6%, 72.7%, 26.3%] respectively.

Inhaled corticosteroids are widely available, inexpensive in most jurisdictions, have few reported severe side effects and are likely beneficial based on the total evidence to date.

Read more... about Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

On 29 Oct, 2021 By admin 0 Comments

October 28, 2021

Background

The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community.

Methods

Read more... about Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study

On 25 Oct, 2021 By admin 0 Comments

October, 2021

Abstract

Background: Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19) lasts longer than 6 months is unclear.

Read more... about Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study

Pages